Minute Insight: Abbott Receives US FDA Clearance For Spinal Cord Stimulator

Abbott announced on 19 December that the US Food and Drug Administration has approved its Eterna spinal cord stimulation system (SCS) for treating chronic pain with low-dose BURSTDR stimulation.

Minute Insight
• Source: Informa/Alamy

More from Approvals

More from Policy & Regulation